• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION AGENT?; DRUG-ELUTING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION AGENT?; DRUG-ELUTING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY CATHETER Back to Search Results
Model Number H7493960815350
Medical Device Problem Codes Break (1069); Entrapment of Device (1212); Deformation Due to Compressive Stress (2889); Device-Device Incompatibility (2919)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/11/2025
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that device entrapped and shaft break occurred.The patient presented with coronary artery disease.A 3.50 x 15 mm agent drug-coated balloon (dcb) was selected for percutaneous coronary intervention (pci).During insertion, the balloon became stuck within the guide extension, resulting in shaft bent and brake.The procedure was successfully completed with another device.There was no patient complications reported, and the patient was fully recovered.
 
Additional Manufacturer Narrative
H6: device codes updated.
 
Event or Problem Description
It was reported that device entrapped and shaft break occurred.The patient presented with coronary artery disease.A 3.50 x 15 mm agent drug-coated balloon (dcb) was selected for percutaneous coronary intervention (pci).During insertion, the balloon became stuck within the guide extension, resulting in shaft bent and brake.The procedure was successfully completed with another device.There was no patient complications reported, and the patient was fully recovered.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AGENT?
Common Device Name
DRUG-ELUTING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY CATHETER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
HEMOTEQ AG
adenauerstrasse 15
wuerselen 52146
GM   52146
Manufacturer Contact
mark mischke
4100 hamline ave n
arden hills, MN 55112
7634941632
MDR Report Key23756759
Report Number2124215-2025-89782
Device Sequence Number13118761
Product Code OOB
UDI-Device Identifier00191506014766
UDI-Public(01)00191506014766(17)270312(10)2557H25
Combination Product (Y/N)Y
Initial Reporter StateIL
Initial Reporter CountryUS
PMA/510(K) Number
P230035
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 01/02/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberH7493960815350
Device Catalogue NumberH7493960815350
Device Lot Number02557H25
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 11/12/2025
Supplement Date Received by Manufacturer12/11/2025
Initial Report FDA Received Date12/09/2025
Supplement Report FDA Received Date01/02/2026
Date Device Manufactured03/12/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-